Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
13 studies found for:    Multifocal Motor Neuropathy

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
Condition: Multifocal Motor Neuropathy
Intervention: Drug: NPB-01
2 Completed Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Drug: Subcutaneous immunoglobulin;   Drug: Intravenous immunoglobulin
3 Completed
Has Results 		Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Biological: Immune Globulin Intravenous (human), 10%;   Biological: 0.25% human albumin solution (Placebo)
4 Not yet recruiting Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
Condition: Multifocal Motor Neuropathy
Interventions: Drug: HyQvia;   Drug: Subcuvia
5 Not yet recruiting HyQvia in Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Intervention: Drug: rHuPH20
6 Completed
Has Results 		A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
Condition: Multifocal Motor Neuropathy (MMN)
Intervention: Biological: Vivaglobin
7 Completed Effect of Resistance and Aerobic Exercise in CIDP or MMN
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy;   Multifocal Motor Neuropathy
Interventions: Other: Resistance training;   Other: Aerobic training
8 Completed LIME Study (LFB IVIg MMN Efficacy Study)
Condition: Motor Neuron Disease
Interventions: Drug: Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL);   Drug: Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)
9 Completed Immunoglobulin Dosage and Administration Form in CIDP and MMN
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy;   Multifocal Motor Neuropathy;   Hemolytic Anemia
Intervention: Drug: Immunoglobulins
10 Active, not recruiting Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Conditions: Guillain-Barre Syndrome;   CIDP;   Multifocal Motor Neuropathy
Intervention:
11 Recruiting sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions: Procedure: Lumbar puncture;   Procedure: Blood sample
12 Recruiting A Study to Evaluate the Performance of a Diagnostic Test in ALS
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Procedure: Lumbar puncture
13 Not yet recruiting Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Procedure: Muscle Magnetic Resonance Imaging (RMI) evaluation;   Device: MRI
To Top

† Indicates status has not been verified in more than two years